Microbiome Drug Development
Explore the Microbiome Like Never Before
The path to FDA approval is a long one. Don’t let the complexity of the microbiome slow you down.
By leveraging an expertly curated library of metabolites affecting microbiome function, you will gain a deep understanding of bacterial function, interactions, and impact on patients.
Achieve peak success on your drug development path.
Metabolomics allows researchers to see exactly what is happening and provides the needed insight to select which microbes and pathways to target for the desired therapeutic effect.
With our proprietary platform and industry leading compound library, we can detect microbial-derived biochemicals produced in the gut entering the bloodstream, crossing the gut-brain axis, and interacting with other functional organs.
Save time and create clarity on MoA, efficacy, dose, and toxicity effects with a functional readout from our library of over 5,400 metabolites covering 70 major biochemical pathways.
From discovery to commercialization, improve biological understanding by tracking biomarkers with targeted metabolite assays.
With our team of PhD’s and 20+ years’ experience in metabolomics, you get access to deep biological insights about pathway impacts, disease states, and health effects.
We’ve collaborated with DNA Genotek to develop OMNImet™•GUT, the first and only solution designed for ambient-temperature storage and stabilization of human fecal samples for metabolomic analysis.
Explore Like Never Before
Microbiome SmartPanel™
The Microbiome SmartPanel demystifies the gut microbiome by focusing on biologically relevant microbial and host-derived metabolites, bacterial signaling molecules, and xenobiotics to give deep insight into microbiome function and impact on host health.
Our proprietary visualization tool allows you to explore 13 microbiome pathways and quickly make connections to the impact of your therapeutic on the host microbiome. The comprehensive pathway knowledge base gives you instant access to microbiome-relevant disease associations and biological impact.
Get a Full Picture
Microbiome Global Assay
By moving beyond genomics and incorporating a functional readout of bacterial activity into your microbiome discovery platform, you’ll be equipped with the foundational insights necessary to realize the full potential of your microbiome therapeutic. Understand true cause and impact in vivo to prove safety and efficacy with the measurable outcomes that only metabolomics can deliver.
With our LC-MS global metabolomics platform and library of 5,400+ metabolites covering 70 major biochemical pathways you will get the most comprehensive view of host and microbiome interactions.
Absolute Quantification
Microbiome Targeted Assays
Build upon the system-wide view of Metabolon’s global metabolomics with additional insights from a series of microbiome focused Targeted Assays. Measure the effects of microbiome-related metabolites with absolute quantification for the most precise and systematic view of microbiome related activity.
Short Chain Fatty Acids
Bile Acids
Sulfated Bile Acids
Trimethylamine N-Oxide (TMAO)
…and more
Kynurenine/Tryptophan Ratio
Serotonin (5-HT)
Indoles
Vancomycin
Contact Us or Request a Demo
Request a quote for our services, get more information on sample types and handling procedures, or request a hands-on demo of our innovative SmartPanel visualizations tools.
617 Davis Drive, Suite 100
Morrisville, NC 27560
Mailing Address:
P.O. Box 110407
Research Triangle Park, NC 27709
Metabolon GmbH
Zeppelinstraße 3
85399 Hallbergmoos
Germany
